York Hildebrandt

Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients

Jens Panse, Kay Friedrichs, Alexander Marx et al. · British Journal of Cancer · 2008 · 132 citations · Full text

Medicine, Cancer Biology, Oncology +14

Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis

Haefaa Alchalby, Anita Badbaran, Tatjana Zabelina et al. · Blood · 2010 · 112 citations

Medicine, Genetics, Hematology +14

Cancer‐testis antigen expression and its epigenetic modulation in acute myeloid leukemia

Djordje Atanackovic, Tim Luetkens, Benjamin Kloth et al. · American Journal of Hematology · 2011 · 105 citations · Full text

Medicine, Molecular Biology, Oncology +17

Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44+) and T (HLA-DR+) cells

Michael Lioznov, Franz Albert Hoffmann, York Hildebrandt et al. · Bone Marrow Transplantation · 2009 · 100 citations

Medicine, Hematology, Oncology +14

Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells

Djordje Atanackovic, York Hildebrandt, Adam Jadczak et al. · Haematologica · 2009 · 97 citations · Full text

Medicine, Cancer Biology, Oncology +15